These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8354771)
1. A study comparing paroxetine placebo and imipramine in depressed patients. Feighner JP; Cohn JB; Fabre LF; Fieve RR; Mendels J; Shrivastava RK; Dunbar GC J Affect Disord; 1993 Jun; 28(2):71-9. PubMed ID: 8354771 [TBL] [Abstract][Full Text] [Related]
2. A comparison of paroxetine, imipramine and placebo in depressed out-patients. Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664 [TBL] [Abstract][Full Text] [Related]
3. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Ohrberg S; Christiansen PE; Severin B; Calberg H; Nilakantan B; Borup A; Søgaard J; Larsen SB; Loldrup D; Bahr B Acta Psychiatr Scand; 1992 Dec; 86(6):437-44. PubMed ID: 1471536 [TBL] [Abstract][Full Text] [Related]
4. Paroxetine in major depression: a double-blind trial with imipramine and placebo. Cohn JB; Wilcox CS J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826 [TBL] [Abstract][Full Text] [Related]
5. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients. Feighner JP Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008 [TBL] [Abstract][Full Text] [Related]
6. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients. Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467 [TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of paroxetine with imipramine in the long-term treatment of depression. Claghorn JL; Feighner JP J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):23S-27S. PubMed ID: 8106652 [TBL] [Abstract][Full Text] [Related]
8. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Lauritzen L; Odgaard K; Clemmesen L; Lunde M; Ohrström J; Black C; Bech P Acta Psychiatr Scand; 1996 Oct; 94(4):241-51. PubMed ID: 8911559 [TBL] [Abstract][Full Text] [Related]
9. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients. Fabre LF J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Keller MB; Ryan ND; Strober M; Klein RG; Kutcher SP; Birmaher B; Hagino OR; Koplewicz H; Carlson GA; Clarke GN; Emslie GJ; Feinberg D; Geller B; Kusumakar V; Papatheodorou G; Sack WH; Sweeney M; Wagner KD; Weller EB; Winters NC; Oakes R; McCafferty JP J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):762-72. PubMed ID: 11437014 [TBL] [Abstract][Full Text] [Related]
11. Direct cost of depression: analysis of treatment costs of paroxetine versus Imipramine in Canada. Lapierre Y; Bentkover J; Schainbaum S; Manners S Can J Psychiatry; 1995 Sep; 40(7):370-7. PubMed ID: 8548716 [TBL] [Abstract][Full Text] [Related]
12. A placebo- and imipramine-controlled study of paroxetine. Cohn JB; Crowder JE; Wilcox CS; Ryan PJ Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697 [TBL] [Abstract][Full Text] [Related]
13. Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients. Elliott AJ; Uldall KK; Bergam K; Russo J; Claypoole K; Roy-Byrne PP Am J Psychiatry; 1998 Mar; 155(3):367-72. PubMed ID: 9501747 [TBL] [Abstract][Full Text] [Related]
14. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Feighner JP; Boyer WF J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824 [TBL] [Abstract][Full Text] [Related]
15. Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Feighner JP; Boyer WF Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763 [TBL] [Abstract][Full Text] [Related]
16. Paroxetine in the treatment of Chinese patients with depressive episode: a double-blind randomized comparison with imipramine. Chiu HJ; Hong CJ; Chan CH Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):418-23. PubMed ID: 8803304 [TBL] [Abstract][Full Text] [Related]
17. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group. Ravindran AV; Judge R; Hunter BN; Bray J; Morton NH J Clin Psychiatry; 1997 Mar; 58(3):112-8. PubMed ID: 9108813 [TBL] [Abstract][Full Text] [Related]
18. A double-blind comparison of paroxetine, imipramine, and placebo in major depression. Shrivastava RK; Shrivastava SH; Overweg N; Blumhardt CL J Clin Psychiatry; 1992 Feb; 53 Suppl():48-51. PubMed ID: 1531825 [TBL] [Abstract][Full Text] [Related]
19. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. Stuppaeck CH; Geretsegger C; Whitworth AB; Schubert H; Platz T; König P; Hinterhuber H; Fleischhacker WW J Clin Psychopharmacol; 1994 Aug; 14(4):241-6. PubMed ID: 7962679 [TBL] [Abstract][Full Text] [Related]
20. Study 329 continuation phase: Safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression. Le Noury J; Nardo JM; Healy D; Jureidini J; Raven M; Tufanaru C; Abi-Jaoude E Int J Risk Saf Med; 2016 Sep; 28(3):143-61. PubMed ID: 27662279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]